HRP970296A2 - Novel pyrrole derivatives - Google Patents
Novel pyrrole derivativesInfo
- Publication number
- HRP970296A2 HRP970296A2 HR60/018,691A HRP970296A HRP970296A2 HR P970296 A2 HRP970296 A2 HR P970296A2 HR P970296 A HRP970296 A HR P970296A HR P970296 A2 HRP970296 A2 HR P970296A2
- Authority
- HR
- Croatia
- Prior art keywords
- pyrrole derivatives
- novel pyrrole
- novel
- derivatives
- pyrrole
- Prior art date
Links
- 150000003233 pyrroles Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/333—Radicals substituted by oxygen or sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Transplantation (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1869196P | 1996-05-30 | 1996-05-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP970296A2 true HRP970296A2 (en) | 1998-04-30 |
Family
ID=21789298
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR60/018,691A HRP970296A2 (en) | 1996-05-30 | 1997-05-28 | Novel pyrrole derivatives |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US5952368A (de) |
| EP (1) | EP0906279B1 (de) |
| JP (1) | JP3142581B2 (de) |
| KR (1) | KR100303377B1 (de) |
| CN (1) | CN1225629A (de) |
| AR (1) | AR007297A1 (de) |
| AT (1) | ATE225333T1 (de) |
| AU (1) | AU717602B2 (de) |
| BR (1) | BR9709497A (de) |
| CA (1) | CA2256609C (de) |
| CO (1) | CO4960660A1 (de) |
| DE (1) | DE69716061T2 (de) |
| DK (1) | DK0906279T3 (de) |
| ES (1) | ES2182090T3 (de) |
| HR (1) | HRP970296A2 (de) |
| MA (1) | MA24346A1 (de) |
| PT (1) | PT906279E (de) |
| TR (1) | TR199802456T2 (de) |
| TW (1) | TW415946B (de) |
| WO (1) | WO1997046524A1 (de) |
| ZA (1) | ZA974538B (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA008242B1 (ru) | 1999-12-08 | 2007-04-27 | Фармация Корпорейшн | Композиции на основе ингибитора циклооксигеназы-2 с быстро наступающим терапевтическим действием и способы лечения заболеваний |
| AR038957A1 (es) | 2001-08-15 | 2005-02-02 | Pharmacia Corp | Terapia de combinacion para el tratamiento del cancer |
| AU2003208952B2 (en) * | 2002-01-30 | 2008-04-24 | Amgen Inc. | Heterocyclic arylsulfonamidobenzylic compounds |
| TWI372050B (en) * | 2003-07-03 | 2012-09-11 | Astex Therapeutics Ltd | (morpholin-4-ylmethyl-1h-benzimidazol-2-yl)-1h-pyrazoles |
| WO2005123671A1 (ja) * | 2004-06-22 | 2005-12-29 | Taisho Pharmaceutical Co., Ltd. | ピロール誘導体 |
| KR101334511B1 (ko) | 2004-12-30 | 2013-11-29 | 아스텍스 테라퓨틱스 리미티드 | Ｃｄｋ, ｇｓｋ 및 오로라 키나아제의 활성을 조절하는피라졸 화합물 |
| WO2007077435A1 (en) * | 2005-12-30 | 2007-07-12 | Astex Therapeutics Limited | Pharmaceutical compounds |
| US20110159111A1 (en) * | 2006-06-29 | 2011-06-30 | Astex Therapeutics Limited | Pharmaceutical combinations |
| EP2049119A2 (de) * | 2006-06-29 | 2009-04-22 | Astex Therapeutics Limited | Pharmazeutische kombinationen von 1-cyclopropyl-3-[3-(5-morphoolin-4-ylmethyl-1h-benzoimidazol-2-yl)-1h-1-pyrazol-4-yl]-harnstoff |
| US10358408B2 (en) * | 2017-12-22 | 2019-07-23 | Polycarbon Industries, Inc. | Synthesis of azelaic acid |
| CA3209491A1 (en) | 2021-03-15 | 2022-09-22 | Saul Yedgar | Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory disease |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3752826A (en) * | 1970-01-26 | 1973-08-14 | Mcneilab Inc | Aroyl substituted pyrroles |
| US4089969A (en) * | 1976-07-14 | 1978-05-16 | Syntex (U.S.A.) Inc. | 5-Aroyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid derivatives and process for the production thereof |
| ZA825227B (en) * | 1981-07-22 | 1984-03-28 | Syntex Inc | Substituted pyrrolidine cardiovascular system regulators antihypertensives |
| IL86462A (en) * | 1987-05-29 | 1992-12-01 | Fujisawa Pharmaceutical Co | Alkanesulfonanilide derivatives, processes for preparation thereof and pharmaceutical compositions comprising the same |
| US5622948A (en) * | 1994-12-01 | 1997-04-22 | Syntex (U.S.A.) Inc. | Pyrrole pyridazine and pyridazinone anti-inflammatory agents |
-
1997
- 1997-05-21 DE DE69716061T patent/DE69716061T2/de not_active Expired - Fee Related
- 1997-05-21 CN CN97196566A patent/CN1225629A/zh active Pending
- 1997-05-21 AT AT97925931T patent/ATE225333T1/de not_active IP Right Cessation
- 1997-05-21 JP JP10500147A patent/JP3142581B2/ja not_active Expired - Fee Related
- 1997-05-21 WO PCT/EP1997/002587 patent/WO1997046524A1/en not_active Ceased
- 1997-05-21 EP EP97925931A patent/EP0906279B1/de not_active Expired - Lifetime
- 1997-05-21 TR TR1998/02456T patent/TR199802456T2/xx unknown
- 1997-05-21 AU AU30913/97A patent/AU717602B2/en not_active Ceased
- 1997-05-21 CA CA002256609A patent/CA2256609C/en not_active Expired - Fee Related
- 1997-05-21 ES ES97925931T patent/ES2182090T3/es not_active Expired - Lifetime
- 1997-05-21 BR BR9709497A patent/BR9709497A/pt unknown
- 1997-05-21 DK DK97925931T patent/DK0906279T3/da active
- 1997-05-21 PT PT97925931T patent/PT906279E/pt unknown
- 1997-05-21 KR KR1019980709759A patent/KR100303377B1/ko not_active Expired - Fee Related
- 1997-05-23 ZA ZA9704538A patent/ZA974538B/xx unknown
- 1997-05-27 AR ARP970102246A patent/AR007297A1/es not_active Application Discontinuation
- 1997-05-28 HR HR60/018,691A patent/HRP970296A2/xx not_active Application Discontinuation
- 1997-05-28 CO CO97029326A patent/CO4960660A1/es unknown
- 1997-05-28 US US08/864,703 patent/US5952368A/en not_active Expired - Fee Related
- 1997-05-29 TW TW086107344A patent/TW415946B/zh not_active IP Right Cessation
- 1997-05-30 MA MA24642A patent/MA24346A1/fr unknown
-
1999
- 1999-03-24 US US09/275,542 patent/US6136844A/en not_active Expired - Fee Related
- 1999-03-24 US US09/275,540 patent/US6127402A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0906279A1 (de) | 1999-04-07 |
| WO1997046524A1 (en) | 1997-12-11 |
| ES2182090T3 (es) | 2003-03-01 |
| EP0906279B1 (de) | 2002-10-02 |
| US6136844A (en) | 2000-10-24 |
| US5952368A (en) | 1999-09-14 |
| CN1225629A (zh) | 1999-08-11 |
| JPH11511755A (ja) | 1999-10-12 |
| MA24346A1 (fr) | 1998-07-01 |
| BR9709497A (pt) | 1999-08-10 |
| CA2256609A1 (en) | 1997-12-11 |
| ZA974538B (en) | 1997-12-01 |
| AR007297A1 (es) | 1999-10-27 |
| AU717602B2 (en) | 2000-03-30 |
| KR20000016191A (ko) | 2000-03-25 |
| ATE225333T1 (de) | 2002-10-15 |
| DE69716061D1 (de) | 2002-11-07 |
| JP3142581B2 (ja) | 2001-03-07 |
| US6127402A (en) | 2000-10-03 |
| TR199802456T2 (xx) | 1999-02-22 |
| KR100303377B1 (ko) | 2001-12-12 |
| TW415946B (en) | 2000-12-21 |
| AU3091397A (en) | 1998-01-05 |
| PT906279E (pt) | 2003-02-28 |
| CA2256609C (en) | 2005-07-26 |
| CO4960660A1 (es) | 2000-09-25 |
| DE69716061T2 (de) | 2003-08-14 |
| DK0906279T3 (da) | 2003-02-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP9700954A0 (en) | 6-ohenylpyridyl-2-amine derivatives | |
| HRP970346A2 (en) | Phenylamino-substituted tricyclic derivatives | |
| ZA9710906B (en) | 6-Phenylpyridyl-2-amine derivatives | |
| AP9700955A0 (en) | Lactam derivatives | |
| NZ330954A (en) | 19-nor-pregnene derivatives | |
| ZA9510027B (en) | Pyrrole derivatives | |
| ZA974053B (en) | Alkylaminobenzothiazole and -benzoxazole derivatives | |
| HUP9701835A3 (en) | Vinyl-pirrolidinone-cephalosporin derivatives | |
| IL129418A0 (en) | 2-Methoxyphenylpiperazine derivatives | |
| ZA974538B (en) | Novel pyrrole derivatives. | |
| IL125149A0 (en) | Pyrazol-4-yl-hetaroyl derivatives | |
| PL334558A1 (en) | Cephalosporinic derivatives | |
| HU9701479D0 (en) | N-benzylazolium derivatives | |
| GB9604996D0 (en) | Benzodiazonine derivatives | |
| GB9603226D0 (en) | Heterocyclyl-ergoline derivatives | |
| GB9600063D0 (en) | Guaridine derivatives | |
| IL122560A0 (en) | Use for pyrrole derivatives | |
| GB9702049D0 (en) | Tetrahhydroisoquinoline derivatives | |
| IL125974A0 (en) | 2-thioxotetrahydropyrimidin-4-one derivatives | |
| IL130283A0 (en) | Polysaccharide-peptide derivatives | |
| GB9614247D0 (en) | Pyrrole derivatives | |
| HU9601036D0 (en) | Aryl-sulfonyl-hydroxamic-acid derivatives | |
| SG33609A1 (en) | Pyrrole derivatives | |
| IL145863A (en) | Benzothiophenecarboxamide derivatives | |
| SG67992A1 (en) | N-benzylazolium derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A1OB | Publication of a patent application | ||
| AIPI | Request for the grant of a patent on the basis of a substantive examination of a patent application | ||
| ODBC | Application rejected |